Carfilzomib-induced thrombotic microangiopathy (TMA): an under-recognised spectrum of disease from microangiopathic haemolysis to subclinical TMA

Detalles Bibliográficos
Autores principales: Ponraj, Royston, Bryant, Adam, Dunlop, Lindsay, Range, Heather, Cobrador, Cherry, Ling, Silvia, Hsu, Danny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371986/
https://www.ncbi.nlm.nih.gov/pubmed/37495597
http://dx.doi.org/10.1038/s41408-023-00885-9
_version_ 1785078267720499200
author Ponraj, Royston
Bryant, Adam
Dunlop, Lindsay
Range, Heather
Cobrador, Cherry
Ling, Silvia
Hsu, Danny
author_facet Ponraj, Royston
Bryant, Adam
Dunlop, Lindsay
Range, Heather
Cobrador, Cherry
Ling, Silvia
Hsu, Danny
author_sort Ponraj, Royston
collection PubMed
description
format Online
Article
Text
id pubmed-10371986
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-103719862023-07-28 Carfilzomib-induced thrombotic microangiopathy (TMA): an under-recognised spectrum of disease from microangiopathic haemolysis to subclinical TMA Ponraj, Royston Bryant, Adam Dunlop, Lindsay Range, Heather Cobrador, Cherry Ling, Silvia Hsu, Danny Blood Cancer J Correspondence Nature Publishing Group UK 2023-07-26 /pmc/articles/PMC10371986/ /pubmed/37495597 http://dx.doi.org/10.1038/s41408-023-00885-9 Text en © Crown 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correspondence
Ponraj, Royston
Bryant, Adam
Dunlop, Lindsay
Range, Heather
Cobrador, Cherry
Ling, Silvia
Hsu, Danny
Carfilzomib-induced thrombotic microangiopathy (TMA): an under-recognised spectrum of disease from microangiopathic haemolysis to subclinical TMA
title Carfilzomib-induced thrombotic microangiopathy (TMA): an under-recognised spectrum of disease from microangiopathic haemolysis to subclinical TMA
title_full Carfilzomib-induced thrombotic microangiopathy (TMA): an under-recognised spectrum of disease from microangiopathic haemolysis to subclinical TMA
title_fullStr Carfilzomib-induced thrombotic microangiopathy (TMA): an under-recognised spectrum of disease from microangiopathic haemolysis to subclinical TMA
title_full_unstemmed Carfilzomib-induced thrombotic microangiopathy (TMA): an under-recognised spectrum of disease from microangiopathic haemolysis to subclinical TMA
title_short Carfilzomib-induced thrombotic microangiopathy (TMA): an under-recognised spectrum of disease from microangiopathic haemolysis to subclinical TMA
title_sort carfilzomib-induced thrombotic microangiopathy (tma): an under-recognised spectrum of disease from microangiopathic haemolysis to subclinical tma
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371986/
https://www.ncbi.nlm.nih.gov/pubmed/37495597
http://dx.doi.org/10.1038/s41408-023-00885-9
work_keys_str_mv AT ponrajroyston carfilzomibinducedthromboticmicroangiopathytmaanunderrecognisedspectrumofdiseasefrommicroangiopathichaemolysistosubclinicaltma
AT bryantadam carfilzomibinducedthromboticmicroangiopathytmaanunderrecognisedspectrumofdiseasefrommicroangiopathichaemolysistosubclinicaltma
AT dunloplindsay carfilzomibinducedthromboticmicroangiopathytmaanunderrecognisedspectrumofdiseasefrommicroangiopathichaemolysistosubclinicaltma
AT rangeheather carfilzomibinducedthromboticmicroangiopathytmaanunderrecognisedspectrumofdiseasefrommicroangiopathichaemolysistosubclinicaltma
AT cobradorcherry carfilzomibinducedthromboticmicroangiopathytmaanunderrecognisedspectrumofdiseasefrommicroangiopathichaemolysistosubclinicaltma
AT lingsilvia carfilzomibinducedthromboticmicroangiopathytmaanunderrecognisedspectrumofdiseasefrommicroangiopathichaemolysistosubclinicaltma
AT hsudanny carfilzomibinducedthromboticmicroangiopathytmaanunderrecognisedspectrumofdiseasefrommicroangiopathichaemolysistosubclinicaltma

Ejemplares similares